Who owns GlaxoSmithKline?

Key details on GlaxoSmithKline (Ticker: GSK)

Who owns GlaxoSmithKline?

Is GSK a good stock to own? Find out who bought GlaxoSmithKline, who sold GlaxoSmithKline (GSK) stock, and who holds a large position in GlaxoSmithKline.

Fund Name Number of Shares Share Valuation As Of
Gruss & Co 25.33M $547.95M Sept. 30, 2012
FMR 13.70M $552.97M Dec. 31, 2015
JPMORGAN CHASE & CO 12.52M $505.10M Dec. 31, 2015
Dodge & Cox 12.48M $519.67M June 30, 2015
Hotchkis and Wiley Capital Management 12.10M $488.35M Dec. 31, 2015
Royal Bank of Canada 11.94M $481.84M Dec. 31, 2015
Fisher Investments 11.66M $499.89M March 31, 2016
Wells Fargo & Company 11.07M $446.51M Dec. 31, 2015
Bank of America Corporation 10.92M $502.22M Sept. 30, 2014
STATE STREET CORPORATION 10.34M $417.10M Dec. 31, 2015
PRIMECAP Management Company 9.18M $490.37M March 31, 2014
Renaissance Technologies 8.87M $474.34M June 30, 2014
Inves 8.86M $415.41M March 31, 2013
T. Rowe Price Associates 8.78M $405.42M March 31, 2015
Barclays 8.27M $380.51M March 31, 2015

Who sold GlaxoSmithKline?

Fund Name Date Sold Number of Shares Sold Share Valuation
Johnson Investment Counsel June 30, 2011 19.93M $947.34M
Allianz Global Investors of America June 30, 2011 10.17M $435.88M
Brandes Investment Partners March 31, 2009 9.46M $293.98M